The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Effects of Ethosuximide on the Pilocarpine Induced Seizure in Rat Model of Neuronal Migration Disorder

  • Kim, Byung-Kon (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University) ;
  • Choi, In-Sun (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University) ;
  • Cho, Jin-Hwa (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University) ;
  • Jang, Il-Sung (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University) ;
  • Lee, Maan-Gee (Departments of Pharmacology, College of Medicine, Kyungpook National University) ;
  • Choi, Byung-Ju (Departments of Dental Pharmacology, College of Medicine, Kyungpook National University)
  • Published : 2006.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Cortical malformation-associated epileptic seizures are resistant to conventional anticonvulsant drugs. Relatively little research has been conducted on the effects of antiepileptic drugs (AEDs) on seizure activity in a rat model of dysplasia. We have used rats exposed to methylazoxymethanol acetate (MAM) in utero, an animal model featuring nodular heterotopia, to investigate the effects of ethosuximide (ETX) in the dysplastic brain. Pilocarpine was used to induce acute seizure in MAM-exposed and age-matched vehicle-injected control animals. Field potential recordings were used to monitor the amplitude and number of population spikes, and paired pulse inhibition in response to stimulation of the commissural pathway. Pharmaco-resistance was tested by measuring seizure latencies after pilocarpine administration (320 mg/kg, Lp.) with and without pre-treatment with ETX. Pre-treatment with 300 mg of ETX significantly prolonged the latency to the status epilepticus (SE) in both control and MAM-treated groups. Pre-treatment with ETX 100mg and ETX 200 mg had little effect in MAMexposed rats. However, ETX 200 mg prolonged the latency to the SE in control groups. Spontaneous field potential and secondary after-discharges were higher for MAM-treated rat in comparison with control rats injects with ETX. The main findings of this study are that acute seizures initiated in MAM-exposed rats are relatively resistant to standard ETX assessed in vivo. These data suggest that ETX do not prolong seizure latencies in MAM-rats exposed to pilocarpine.

Keywords

References

  1. Aicardi J. The place of neuronal migration abnormalities in child neurology. Can J Neurol Sci 21: 185-193, Review, 1994 https://doi.org/10.1017/S0317167100041159
  2. Amano S, Ihara N, Umeura S. Development of novel rat mutant with spontaneous limbic-like seizures. Am J Pathol 149: 329- 336, 1996
  3. Baba A, Okumura S, Mizuo H, Iwata H, The inhibition of diazepam and gamma-aminobutyric acid of depolarization-induced release of [14C] cysteine sulfinate and [3H] glutamate in rat hippocampal slices. J Neurochem 40: 280-284, 1983 https://doi.org/10.1111/j.1471-4159.1983.tb12683.x
  4. Babb TL, Ying Z, Hadam J, Penrod C. Glutamate receptor mechanisms in human epileptic dysplastic cortex. Epilepsy Res 32: 24- 33, 1998 https://doi.org/10.1016/S0920-1211(98)00037-0
  5. Baraban SC, Schwartzkroin PA. Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders: prenatal methylazoxymethanol treatment. Epilepsy Res 22: 145-156, 1995 https://doi.org/10.1016/0920-1211(95)00045-3
  6. Baraban SC, Wenzel HJ, Hochman DW, Schwartzkroin PA. Characterization of heterotopic cell clusters in the hippocampus of rats exposed to methylaxzoxymethanol in utero. Epilepsy Res 39: 87-102, 2000 https://doi.org/10.1016/S0920-1211(99)00104-7
  7. Barth PG. Disorders of cerebral migration. Can J Neurol Sci 14: 1-16, 1987 https://doi.org/10.1017/S031716710002610X
  8. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403, 1985 https://doi.org/10.1016/0306-4522(85)90299-4
  9. Bruckner C, Heinemann U. Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res 859: 15-20, 2000 https://doi.org/10.1016/S0006-8993(99)02348-3
  10. Bruckner C, Stenkamp K, Meierkord H, Heinemann U. Epileptiform discharges induced by combined application of bicuculline and 4-aminopyridine are resistant to standard anticonvulsants in slices of rats. Neurosci Lett 268: 163-165, 1999 https://doi.org/10.1016/S0304-3940(99)00341-9
  11. Calcagnotto ME, Maredes MF, Baraban SC. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J Neurosci 22: 7596-7605, 2002 https://doi.org/10.1523/JNEUROSCI.22-17-07596.2002
  12. Castro PA, Pleasure SJ, Baraban SC. Hippocampal heterotopia with molecular and electrophysiological properties of neocortical neurons. Neuroscience 114: 961-972, 2002 https://doi.org/10.1016/S0306-4522(02)00296-8
  13. Cavalheiro EA, Santos NF, Priel MR. The pilocarpine model of epilepsy in mice. Epilepsia 37: 1015-1019, 1996 https://doi.org/10.1111/j.1528-1157.1996.tb00541.x
  14. Chen HX, Roper SN. Reduction of spontaneous inhibitory synaptic activity in experimental heterotopic gray matter. J Neurophysiol 89: 150-158, 2003 https://doi.org/10.1152/jn.00325.2002
  15. Chen S, Hillman DE. Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development. Exp Neurol 94: 103-119, 1986 https://doi.org/10.1016/0014-4886(86)90275-X
  16. Chevassus-au-Louis N, Congar P, Represa A, Ben-Ari Y, Gaiarsa JL. Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci 95: 10263-10268, 1998a
  17. Chevassus-au-Louis N, Ben-Ari Y, Vergnes M. Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol. Brain Res 812: 252-255, 1998b https://doi.org/10.1016/S0006-8993(98)00932-9
  18. Choi IS, Cho JH, Lee MG, Choi BJ. Pilocarpine-induced seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Biol Pharm Bull 28: 1408-1413, 2005 https://doi.org/10.1248/bpb.28.1408
  19. Ciaroni S, Cecchini T, Gazzanelli G, Grande PD. Methylazoxymethanol (MAMac) effects on ontogenesis of the mouse neocortex. J Hirnforsch 30: 699-705, 1989
  20. de Feo MR, Mecarelli O, Ricci GF. Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate. Pharmacol Res 31: 109-114, 1995
  21. Dudek FE, Spitz M. Hypothetical mechanisms for the cellular and neurophysiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization. J Clin Neurophysiol 14: 90-101, Review 1997 https://doi.org/10.1097/00004691-199703000-00002
  22. Dudek FE. Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 46: 8-14, 2005
  23. Duncan JS. The promise of new antiepileptic drugs. Br J Clin Pharmacol 53: 123-131, 2002 https://doi.org/10.1046/j.0306-5251.2001.01540.x
  24. Fleck MW, Hirotsune S, Gambello MJ, Phillips-Tansey E, Suares G, Mervis RF, Wynshaw-Boris A, McBain CJ. Hippocampal abnormalities and enhanced excitability in a murine model of human lissencephaly. J Neurosci 20: 2439-2450, 2000 https://doi.org/10.1523/JNEUROSCI.20-07-02439.2000
  25. Fueta Y, Avoli M. Effects of antiepileptic drugs on 4-aminopyridineinduced epileptiform activitity in young and adult rat hippocampus. Epilepsy Res 12: 207-215, 1992, https://doi.org/10.1016/0920-1211(92)90075-5
  26. Germano IM, Sperber EF, The effects of neuronal migration disorders on seizure susceptibility. Epilepsia 35(Suppl.8): 137, 1994
  27. Germano IM, Sperber EF. Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res 28; 219-222, 1997
  28. Germano IM, Zhang YF, Sperber EF, Moshe SL. Neuronal migration disorders increase susceptibility to hyperthermia-induced seizures in developing rats. Epilepsia 37: 902-910, 1996 https://doi.org/10.1111/j.1528-1157.1996.tb00044.x
  29. Glien M, Brandt C, Potschka H, Loscher W. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43: 350-357, 2002 https://doi.org/10.1046/j.1528-1157.2002.18101.x
  30. Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31: 73-84, 1998 https://doi.org/10.1016/S0920-1211(98)00017-5
  31. Hirabayashi S, Binnie CD, Janota I, Polkey CE. Surgical treatment of epilepsy due to cortical dysplasia: clinical and EEG findings. J Neurol Neurosurg Psychiatry 56: 765-770, 1993 https://doi.org/10.1136/jnnp.56.7.765
  32. Houser CR. Granule cell dispersion in the dentate gyrus of human with temporal lobe epilepsy. Brain Res 535: 195-204, 1990 https://doi.org/10.1016/0006-8993(90)91601-C
  33. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50: 105-123, 2002 https://doi.org/10.1016/S0920-1211(02)00073-6
  34. Loscher W, Honack D. Profile of UCB L059, A novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 232: 147-158, 1993 https://doi.org/10.1016/0014-2999(93)90768-D
  35. Mello LM, Cavalhiero EA, Tan AM. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34: 985-995, 1993 https://doi.org/10.1111/j.1528-1157.1993.tb02123.x
  36. Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y. Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann Neurol 30: 750-757, 1991 https://doi.org/10.1002/ana.410300603
  37. Palmini A. Disorders of cortical development. Curr Opin Neurol 13: 183-192, 2000 https://doi.org/10.1097/00019052-200004000-00012
  38. Prayson RA, Estes ML. Cortical dysplasiz: a histopathologic study of 52 cases of partial lobectomy in patients with epilepsy. Hum Pathol 26: 493-500, 1995 https://doi.org/10.1016/0046-8177(95)90244-9
  39. Racine RJ. Modification of seizure activity by electrical stimulation, II: motor seizure. Electroencephalogr Clin Neurophysiol 32: 281- 294, 1972 https://doi.org/10.1016/0013-4694(72)90177-0
  40. Sancini G, Franceschetti S, Battaglia G, Colacitti C, Di Luca M, Spreafico R, Avanzini G. Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: an intracellular study of identified pyramidal neurones. Neurosci Lett 246: 181-185, 1998 https://doi.org/10.1016/S0304-3940(98)00258-4
  41. Smyth MD, Barbaro NM, Baraban SC. Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia. Epilepsy Res 50: 251-264, 2002 https://doi.org/10.1016/S0920-1211(02)00051-7
  42. Spreafico R, Pasquier B, Minotti L, Garbelli R, Kahane P, Grand S, Benabid A, Tassi L, Avanzini G, Battaglia G, Munari C. Immunocytochemical investigation on dysplastic human tissue from epileptic patients. Epilepsy Res 32: 32-48, 1998
  43. Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, Loscher W, Lowenstein DH, Moshe SL, Noebels JL, Davis M. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 43: 1410- 1420, 2002
  44. Wenzel HJ, Robbins CA, Tsai LH, Schwartzkroin PA. Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. Neurosci Feb 21: 983-998, 2001 https://doi.org/10.1523/JNEUROSCI.21-03-00983.2001
  45. White HS. Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 44(suppl 7): 2-8, 2003
  46. Yamaguchi S, Rogawski MA. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 11: 9- 16, 1992 https://doi.org/10.1016/0920-1211(92)90016-M
  47. Zhu WJ, Roper SN. Reduced inhibition in an animal model of cortical dysplasia. J Neurosci 20(23): 8925-8931, 2000 https://doi.org/10.1523/JNEUROSCI.20-23-08925.2000